Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis
about
The vaginal microbiota: what have we learned after a decade of molecular characterization?Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosisUse of locally delivered dequalinium chloride in the treatment of vaginal infections: a reviewAnaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisationEvaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal MicrobiotaSilver sucrose octasulfate (IASOS™) as a valid active ingredient into a novel vaginal gel against human vaginal pathogens: in vitro antimicrobial activity assessment.Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin.Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microfloraUltra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.Relationship between nugent score and vaginal epithelial exfoliation.The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term.Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis.Group B streptococcus: prevalence in a non-obstetric population.Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocolFactors related to elevated vaginal pH in the first trimester of pregnancy.Easiness of use and validity testing of VS-SENSE device for detection of abnormal vaginal flora and bacterial vaginosis.Aerobic vaginitis in pregnancy.Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysisPrevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity.Treatment of bacterial vaginosis: what we have and what we miss.Diagnosis and management of clinical chorioamnionitis.Diagnostic and therapeutic advancements for aerobic vaginitis.Selecting anti-microbial treatment of aerobic vaginitis.Efficacy of oral moxifloxacin for aerobic vaginitis.Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities.Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women.The vaginal microbiome: new information about genital tract flora using molecular based techniques.Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis.Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American populationDevelopment of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV sheddingMicrobiota of the upper and lower genital tract.Biotherapeutic agents and vaginal health.Organisms associated with bacterial vaginosis in Nigerian women as determined by PCR-DGGE and 16S rRNA gene sequenceRelationship between lactobacilli and opportunistic bacterial pathogens associated with vaginitisEffect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.Bacterial vaginosis--a microbiological and immunological enigma.Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.
P2860
Q21131955-F73F6CE8-04A2-4D20-91DC-EEB05BF4A812Q24799744-81C1D60B-1CAF-4393-9668-5C37E596A144Q26778387-DFF1E69F-CA9A-47DE-9292-7AB6A53F0F22Q28243717-09753CAA-3CEC-43F5-A46F-51DBA84ABE12Q28554228-B5F1322E-ED14-4E85-84A5-CE948F8B2E95Q31162492-9E4B1CEF-DCDE-44B4-993C-347F3ECD6C58Q33430797-ACE32D21-4C1C-4C9B-A734-2094375BDCADQ33458921-D1F989C2-965A-4FB0-862D-CE361A462AFEQ33628455-C49137AB-4204-413D-88D4-5DAA914A4714Q33733200-F2C9307A-B9FF-45EC-B3BA-5ECFACF67A3CQ33745837-1C91E8C2-FA31-432F-84F7-8831B0A80BA3Q33789021-D1C8C54C-D608-41B7-A435-5D5C5894C367Q33827040-FAB67CBA-A5CC-451A-91A8-93C592F1E0FFQ33968645-FD3F865C-0362-4C6E-A533-D2914F7AAA02Q34025678-D78154A3-0AEE-4178-8756-B7FEC1E5334FQ34161236-9A7F74F9-17F5-4290-8F07-D14AD1A4F733Q34189018-229ED827-B4DF-4E70-AFE7-8EB6D677823AQ34192094-5CA40525-4852-4155-8ECF-A5434B36D3BFQ34231180-CE375FBA-506E-4009-A045-F970EC0AF5E6Q34329978-B04563A6-2C40-4F56-9C29-DF523FDDF84BQ34407439-CE8F9897-CA11-4881-873A-81AB444C1AFBQ34432493-8C0E76C2-9C86-48CC-A47A-EAD8B972A29EQ34446129-F47AC240-2357-40EB-A5BB-6797AD0F0150Q34472797-112D44CF-FE66-48DB-A69D-F656134108ACQ34500206-F9D971FE-3C08-4327-9C53-DD2DBF58C114Q34510759-0A3BAD74-01E6-4AF1-9474-D2FFF0D14373Q34571154-B0734EE7-B366-4DC3-BD5A-34594FF0611AQ34663224-3671E1B6-1F7A-4B9C-926D-D875237D41EAQ34745905-75A13449-7F1B-49A5-B85F-EBBA3FDFB306Q35002766-A563447C-D290-497D-8C45-1D4AE30DC2ADQ35123656-485C4EBD-EDB5-4BAA-8232-6E94E15506F3Q35385384-495F6E32-6B75-439E-9CE0-11ECC1BE003EQ35531219-1CD25EF0-88B6-4677-8329-BADACB57A257Q35624293-07766014-D84F-46F0-8380-83292EB4A45BQ35891684-EB1C0B3E-DA8B-430A-88AD-CB56C0B69476Q35902644-4C6C625A-9AC7-431A-890A-1E8F70EB9C52Q35913471-B60F4649-B676-4B08-A2FD-1CD15A881620Q36048582-DCF6C785-B30A-4815-889B-6E0E187440ADQ36050730-1CCF031C-6320-4FEF-BFA2-6A997F10B7CAQ36110963-F29A2703-28E8-4BB4-BE75-681335A000EC
P2860
Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@ast
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@en
type
label
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@ast
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@en
prefLabel
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@ast
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@en
P2093
P2860
P3181
P1476
Definition of a type of abnorm ...... l vaginosis: aerobic vaginitis
@en
P2093
Alfons Dekeersmaecker
Annie Vereecken
Bernard Spitz
Eugene Bosmans
Geert Salembier
Gilbert G.G. Donders
P2860
P3181
P356
10.1111/J.1471-0528.2002.00432.X
P577
2002-01-01T00:00:00Z